| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Connexin 43 | 14 | 2015 | 36 | 2.950 |
Why?
|
| Gap Junctions | 11 | 2015 | 37 | 2.310 |
Why?
|
| Connexins | 6 | 2014 | 12 | 2.150 |
Why?
|
| Cell Communication | 7 | 2014 | 93 | 1.730 |
Why?
|
| Proteasome Endopeptidase Complex | 6 | 2014 | 109 | 1.600 |
Why?
|
| Ubiquitination | 10 | 2013 | 54 | 1.190 |
Why?
|
| rab GTP-Binding Proteins | 3 | 2013 | 11 | 1.090 |
Why?
|
| Endoplasmic Reticulum | 4 | 2014 | 101 | 0.990 |
Why?
|
| Ubiquitins | 5 | 2014 | 45 | 0.950 |
Why?
|
| Cell Cycle Proteins | 9 | 2019 | 220 | 0.870 |
Why?
|
| Nuclear Proteins | 3 | 2018 | 287 | 0.740 |
Why?
|
| Intercellular Junctions | 2 | 2014 | 17 | 0.730 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 3 | 2013 | 6 | 0.690 |
Why?
|
| Carrier Proteins | 3 | 2010 | 287 | 0.690 |
Why?
|
| F-Box Proteins | 4 | 2014 | 6 | 0.680 |
Why?
|
| Hela Cells | 10 | 2015 | 344 | 0.680 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2019 | 121 | 0.670 |
Why?
|
| Ubiquitin-Protein Ligases | 4 | 2014 | 69 | 0.640 |
Why?
|
| Antibodies, Monoclonal | 2 | 2009 | 282 | 0.630 |
Why?
|
| Models, Biological | 8 | 2014 | 642 | 0.620 |
Why?
|
| Animals | 29 | 2019 | 14307 | 0.560 |
Why?
|
| Ubiquitin | 3 | 2010 | 76 | 0.520 |
Why?
|
| Cell Membrane | 3 | 2013 | 360 | 0.510 |
Why?
|
| Oncogenes | 2 | 2012 | 43 | 0.490 |
Why?
|
| Lysosomes | 2 | 2012 | 80 | 0.480 |
Why?
|
| Phosphorylation | 12 | 2018 | 878 | 0.480 |
Why?
|
| Cyclin E | 1 | 2013 | 13 | 0.470 |
Why?
|
| Mice | 17 | 2019 | 5668 | 0.450 |
Why?
|
| Endopeptidases | 2 | 2010 | 58 | 0.450 |
Why?
|
| beta-Transducin Repeat-Containing Proteins | 1 | 2012 | 3 | 0.440 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2011 | 31 | 0.390 |
Why?
|
| Bone Cysts, Aneurysmal | 1 | 2010 | 1 | 0.390 |
Why?
|
| Autocrine Communication | 1 | 2010 | 10 | 0.390 |
Why?
|
| Amines | 1 | 2011 | 38 | 0.390 |
Why?
|
| Quinazolines | 1 | 2011 | 31 | 0.390 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2010 | 22 | 0.390 |
Why?
|
| Osteoblasts | 1 | 2010 | 33 | 0.380 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2011 | 117 | 0.380 |
Why?
|
| Humans | 27 | 2019 | 34853 | 0.350 |
Why?
|
| DNA Replication | 2 | 2019 | 148 | 0.310 |
Why?
|
| Oncogene Protein pp60(v-src) | 2 | 2006 | 8 | 0.310 |
Why?
|
| Signal Transduction | 9 | 2018 | 1802 | 0.300 |
Why?
|
| Immunoprecipitation | 4 | 2013 | 126 | 0.300 |
Why?
|
| Ion Channel Gating | 1 | 2007 | 81 | 0.300 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2018 | 781 | 0.290 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2005 | 8 | 0.270 |
Why?
|
| Protein Transport | 4 | 2012 | 286 | 0.270 |
Why?
|
| Protein Binding | 7 | 2015 | 913 | 0.250 |
Why?
|
| Cell Line | 6 | 2014 | 1289 | 0.240 |
Why?
|
| Cell Adhesion | 2 | 2006 | 209 | 0.240 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2014 | 166 | 0.230 |
Why?
|
| Amino Acid Sequence | 8 | 2014 | 1124 | 0.230 |
Why?
|
| Neoplasms | 2 | 2012 | 1033 | 0.230 |
Why?
|
| Cell Movement | 5 | 2014 | 545 | 0.230 |
Why?
|
| Protein Structure, Tertiary | 5 | 2015 | 383 | 0.220 |
Why?
|
| Sulfoxides | 2 | 2019 | 16 | 0.220 |
Why?
|
| Cell Line, Tumor | 8 | 2019 | 2128 | 0.210 |
Why?
|
| Pyrazoles | 2 | 2019 | 80 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2014 | 245 | 0.210 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2010 | 168 | 0.210 |
Why?
|
| Pyrimidines | 2 | 2019 | 112 | 0.200 |
Why?
|
| Immunoblotting | 2 | 2013 | 170 | 0.200 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2014 | 33 | 0.190 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 605 | 0.190 |
Why?
|
| Molecular Sequence Data | 6 | 2012 | 1490 | 0.180 |
Why?
|
| Microscopy, Confocal | 3 | 2009 | 210 | 0.180 |
Why?
|
| Pyrimidinones | 1 | 2019 | 9 | 0.180 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2019 | 19 | 0.180 |
Why?
|
| Microscopy, Fluorescence | 2 | 2009 | 240 | 0.170 |
Why?
|
| Dogs | 3 | 2011 | 138 | 0.160 |
Why?
|
| Immediate-Early Proteins | 2 | 2010 | 45 | 0.160 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2009 | 445 | 0.160 |
Why?
|
| Blotting, Western | 2 | 2010 | 834 | 0.160 |
Why?
|
| Amino Acid Motifs | 4 | 2014 | 85 | 0.150 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2007 | 49 | 0.150 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2012 | 4 | 0.140 |
Why?
|
| DNA Damage | 1 | 2018 | 341 | 0.130 |
Why?
|
| Mutation | 4 | 2014 | 1023 | 0.130 |
Why?
|
| Transcription Factors | 2 | 2018 | 653 | 0.130 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2014 | 36 | 0.120 |
Why?
|
| Secretory Pathway | 1 | 2014 | 6 | 0.120 |
Why?
|
| Escherichia coli | 2 | 2009 | 436 | 0.120 |
Why?
|
| Rats | 5 | 2011 | 3261 | 0.120 |
Why?
|
| Feedback, Physiological | 1 | 2013 | 28 | 0.120 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2012 | 184 | 0.120 |
Why?
|
| RNA, Messenger | 2 | 2010 | 1152 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2014 | 162 | 0.120 |
Why?
|
| Endocytosis | 1 | 2014 | 104 | 0.120 |
Why?
|
| Protein Folding | 1 | 2014 | 121 | 0.110 |
Why?
|
| Amino Acid Substitution | 2 | 2010 | 122 | 0.110 |
Why?
|
| Nephrology | 1 | 2012 | 17 | 0.110 |
Why?
|
| NF-kappa B p52 Subunit | 1 | 2012 | 3 | 0.110 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2012 | 10 | 0.110 |
Why?
|
| Breast Neoplasms | 2 | 2014 | 1426 | 0.110 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2012 | 11 | 0.110 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2010 | 48 | 0.110 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2012 | 58 | 0.110 |
Why?
|
| Enzyme Activation | 3 | 2014 | 423 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2012 | 39 | 0.110 |
Why?
|
| Cell Cycle | 1 | 2013 | 309 | 0.110 |
Why?
|
| Sulfonamides | 3 | 2019 | 75 | 0.110 |
Why?
|
| Substrate Specificity | 1 | 2012 | 186 | 0.100 |
Why?
|
| Autophagy | 1 | 2012 | 111 | 0.100 |
Why?
|
| Cells, Cultured | 2 | 2013 | 1442 | 0.100 |
Why?
|
| Cell Proliferation | 3 | 2014 | 1149 | 0.100 |
Why?
|
| Culture Media, Conditioned | 1 | 2010 | 44 | 0.100 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2010 | 12 | 0.100 |
Why?
|
| Cullin Proteins | 1 | 2010 | 11 | 0.100 |
Why?
|
| Alkaline Phosphatase | 1 | 2010 | 48 | 0.100 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 52 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2011 | 139 | 0.090 |
Why?
|
| Mutation, Missense | 1 | 2010 | 80 | 0.090 |
Why?
|
| Kidney Failure, Chronic | 1 | 2012 | 231 | 0.090 |
Why?
|
| Drug Design | 1 | 2011 | 154 | 0.090 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2011 | 103 | 0.090 |
Why?
|
| NF-kappa B | 1 | 2012 | 306 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 298 | 0.090 |
Why?
|
| Molecular Structure | 1 | 2011 | 467 | 0.090 |
Why?
|
| Binding Sites | 3 | 2007 | 597 | 0.090 |
Why?
|
| Genetic Vectors | 1 | 2009 | 154 | 0.080 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2010 | 281 | 0.080 |
Why?
|
| Glycogen Synthase Kinase 3 | 3 | 2014 | 27 | 0.080 |
Why?
|
| Morpholines | 2 | 2019 | 65 | 0.080 |
Why?
|
| Mice, SCID | 2 | 2019 | 143 | 0.080 |
Why?
|
| Cloning, Molecular | 1 | 2009 | 310 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2019 | 242 | 0.080 |
Why?
|
| 14-3-3 Proteins | 1 | 2007 | 19 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 1 | 2009 | 649 | 0.080 |
Why?
|
| Cell Differentiation | 1 | 2010 | 562 | 0.080 |
Why?
|
| Indoles | 2 | 2019 | 154 | 0.080 |
Why?
|
| Models, Molecular | 1 | 2011 | 751 | 0.080 |
Why?
|
| Proteins | 1 | 2010 | 352 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 600 | 0.070 |
Why?
|
| RNA-Binding Proteins | 1 | 2007 | 145 | 0.070 |
Why?
|
| Protein Conformation | 1 | 2007 | 350 | 0.070 |
Why?
|
| Oncogene Proteins | 1 | 2005 | 18 | 0.070 |
Why?
|
| Genes, src | 1 | 2005 | 1 | 0.070 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2005 | 6 | 0.070 |
Why?
|
| Models, Chemical | 1 | 2007 | 201 | 0.070 |
Why?
|
| Intracellular Fluid | 1 | 2005 | 26 | 0.070 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2005 | 13 | 0.070 |
Why?
|
| Phosphoserine | 1 | 2005 | 18 | 0.070 |
Why?
|
| Cell Hypoxia | 1 | 2005 | 55 | 0.070 |
Why?
|
| Proline-Rich Protein Domains | 1 | 2005 | 7 | 0.070 |
Why?
|
| src Homology Domains | 1 | 2005 | 13 | 0.070 |
Why?
|
| Calmodulin | 1 | 2005 | 41 | 0.070 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2005 | 42 | 0.070 |
Why?
|
| Protein Interaction Mapping | 1 | 2005 | 57 | 0.070 |
Why?
|
| Protein Phosphatase 1 | 1 | 2005 | 58 | 0.070 |
Why?
|
| Organ Specificity | 1 | 2005 | 123 | 0.060 |
Why?
|
| Spodoptera | 1 | 2004 | 11 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2005 | 342 | 0.060 |
Why?
|
| Piperazines | 2 | 2018 | 109 | 0.060 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2004 | 26 | 0.060 |
Why?
|
| Protein Kinases | 1 | 2004 | 91 | 0.060 |
Why?
|
| Sequence Deletion | 1 | 2004 | 87 | 0.060 |
Why?
|
| Point Mutation | 1 | 2004 | 88 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2012 | 794 | 0.060 |
Why?
|
| Genes, Reporter | 1 | 2004 | 132 | 0.060 |
Why?
|
| Apoptosis | 1 | 2011 | 1317 | 0.060 |
Why?
|
| Astrocytes | 1 | 2005 | 203 | 0.060 |
Why?
|
| DNA Primers | 1 | 2004 | 269 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 2004 | 154 | 0.060 |
Why?
|
| Homeostasis | 1 | 2004 | 172 | 0.060 |
Why?
|
| Cell Division | 1 | 2003 | 296 | 0.050 |
Why?
|
| Calcium | 1 | 2005 | 445 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 485 | 0.050 |
Why?
|
| Protein Structure, Secondary | 2 | 2015 | 172 | 0.050 |
Why?
|
| Peptides | 1 | 2005 | 308 | 0.050 |
Why?
|
| Base Sequence | 1 | 2004 | 932 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2014 | 184 | 0.050 |
Why?
|
| Kidney | 1 | 2004 | 322 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2004 | 486 | 0.050 |
Why?
|
| Male | 3 | 2013 | 18870 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2019 | 2 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 43 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2019 | 29 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2019 | 52 | 0.040 |
Why?
|
| Heterocyclic Compounds, 2-Ring | 1 | 2018 | 3 | 0.040 |
Why?
|
| Pyridazines | 1 | 2018 | 14 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2013 | 229 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 178 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2019 | 396 | 0.040 |
Why?
|
| Female | 4 | 2019 | 19873 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2014 | 968 | 0.030 |
Why?
|
| Pentanones | 1 | 2014 | 4 | 0.030 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2014 | 10 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2014 | 60 | 0.030 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2014 | 18 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2014 | 20 | 0.030 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2014 | 9 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 114 | 0.030 |
Why?
|
| Chickens | 1 | 2015 | 123 | 0.030 |
Why?
|
| Cyclin A | 1 | 2013 | 5 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2014 | 323 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 247 | 0.030 |
Why?
|
| Xenopus | 1 | 2013 | 44 | 0.030 |
Why?
|
| Casein Kinase I | 1 | 2012 | 1 | 0.030 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2012 | 18 | 0.030 |
Why?
|
| Protein Sorting Signals | 1 | 2012 | 26 | 0.030 |
Why?
|
| Propensity Score | 1 | 2012 | 40 | 0.030 |
Why?
|
| Acetylation | 1 | 2012 | 94 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 213 | 0.030 |
Why?
|
| Cadherins | 1 | 2012 | 82 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2012 | 135 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2012 | 110 | 0.030 |
Why?
|
| Lysine | 1 | 2012 | 104 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2012 | 257 | 0.030 |
Why?
|
| Nitrophenols | 1 | 2011 | 4 | 0.030 |
Why?
|
| Benzenesulfonates | 1 | 2011 | 8 | 0.030 |
Why?
|
| Niacinamide | 1 | 2011 | 10 | 0.030 |
Why?
|
| Phenylurea Compounds | 1 | 2011 | 18 | 0.030 |
Why?
|
| Biphenyl Compounds | 1 | 2011 | 52 | 0.020 |
Why?
|
| Pyridines | 1 | 2011 | 113 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2012 | 181 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 580 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 239 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2010 | 249 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2012 | 341 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2012 | 727 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2012 | 1056 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2012 | 897 | 0.020 |
Why?
|
| Cell Survival | 1 | 2011 | 818 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2007 | 63 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 2007 | 86 | 0.020 |
Why?
|
| Serine | 1 | 2007 | 72 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 1300 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2012 | 1961 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2006 | 48 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 2333 | 0.020 |
Why?
|
| Hawaii | 1 | 2012 | 1878 | 0.020 |
Why?
|
| Calcimycin | 1 | 2005 | 11 | 0.020 |
Why?
|
| Ionophores | 1 | 2005 | 12 | 0.020 |
Why?
|
| GTPase-Activating Proteins | 1 | 2005 | 26 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2005 | 83 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2005 | 175 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2005 | 121 | 0.020 |
Why?
|
| Aged | 1 | 2012 | 6448 | 0.010 |
Why?
|
| Middle Aged | 1 | 2012 | 9642 | 0.010 |
Why?
|